FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008471208> ?p ?o ?g. }

• W2008471208 endingPage "3034" @default.
• W2008471208 startingPage "3034" @default.
• W2008471208 abstract "Growth of solid tumors depends largely on the development of a functional vasculature, which has been the focus in anti-tumor therapy since Folkman in 1971 proposed that prohibiting the formation of new vessels could inhibit tumor growth. The recognition of the tumor vascular bed as an important target led to the development of 3 vascular-targeted strategies. I) The anti-angiogenesis strategy that prevents the formation of new blood vessels and normalizes the remaining vessels. II) Applying vasculo-destructive agents to induce apoptosis in the endothelium of the tumor-associated vasculature that results in vascular collapse and tumor necrosis. III) Promoting further abnormalization of the already abnormal features of the tumor-associated vasculature with vaso-active agents to enhance vessel permeability. Tumor necrosis factor alpha (TNF) is a very promising vaso-active agent because of its anti-tumor effects but its severe systemic toxicity is a major drawback. Therefore a new setting, in which the optimal therapeutic benefit of TNF could be exploited, needed to be found. Through an isolated perfusion high dose of TNF can be administered in the blood circulation of the tumor-bearing extremity or organ. Alternatively, systemically low doses can be safely administered for several times. Importantly, TNF has no anti-tumor effect by itself and the combination with a conventional chemotherapeutic drug that targets the tumor cell is a prerequisite for a good tumor response. In this dual approach, TNF enhances intratumoral accumulation of the chemotherapeutic drug resulting in an impressive tumor response." @default.
• W2008471208 created "2016-06-24" @default.
• W2008471208 creator A5088483921 @default.
• W2008471208 date "2008-01-01" @default.
• W2008471208 modified "2023-09-27" @default.
• W2008471208 title "TNF and manipulation of the tumor cell - stromal interface: ways to make chemotherapy effectiv" @default.
• W2008471208 cites W1490892722 @default.
• W2008471208 cites W1552070041 @default.
• W2008471208 cites W1556917336 @default.
• W2008471208 cites W1559937222 @default.
• W2008471208 cites W1579129437 @default.
• W2008471208 cites W1579598940 @default.
• W2008471208 cites W1594538340 @default.
• W2008471208 cites W175938947 @default.
• W2008471208 cites W1769308960 @default.
• W2008471208 cites W1889451488 @default.
• W2008471208 cites W1890068101 @default.
• W2008471208 cites W1930683464 @default.
• W2008471208 cites W1934450921 @default.
• W2008471208 cites W1936102867 @default.
• W2008471208 cites W1963827572 @default.
• W2008471208 cites W1966756337 @default.
• W2008471208 cites W1967082864 @default.
• W2008471208 cites W1968401667 @default.
• W2008471208 cites W1971798677 @default.
• W2008471208 cites W1977887541 @default.
• W2008471208 cites W1978139448 @default.
• W2008471208 cites W1979887297 @default.
• W2008471208 cites W1981856846 @default.
• W2008471208 cites W1982213879 @default.
• W2008471208 cites W1984601537 @default.
• W2008471208 cites W1986625425 @default.
• W2008471208 cites W1990395464 @default.
• W2008471208 cites W1992567223 @default.
• W2008471208 cites W2001224424 @default.
• W2008471208 cites W2002621910 @default.
• W2008471208 cites W2004554331 @default.
• W2008471208 cites W2009038500 @default.
• W2008471208 cites W2011217812 @default.
• W2008471208 cites W2021226726 @default.
• W2008471208 cites W2025036947 @default.
• W2008471208 cites W2025811635 @default.
• W2008471208 cites W2029714434 @default.
• W2008471208 cites W2036164831 @default.
• W2008471208 cites W2044235770 @default.
• W2008471208 cites W2048826766 @default.
• W2008471208 cites W2048982856 @default.
• W2008471208 cites W2051962533 @default.
• W2008471208 cites W2053872302 @default.
• W2008471208 cites W2053938092 @default.
• W2008471208 cites W2057123987 @default.
• W2008471208 cites W2059927830 @default.
• W2008471208 cites W2062036842 @default.
• W2008471208 cites W2062228279 @default.
• W2008471208 cites W2065985007 @default.
• W2008471208 cites W2067055586 @default.
• W2008471208 cites W2070297702 @default.
• W2008471208 cites W2071021121 @default.
• W2008471208 cites W2071895235 @default.
• W2008471208 cites W2072304704 @default.
• W2008471208 cites W2072918578 @default.
• W2008471208 cites W2080965558 @default.
• W2008471208 cites W2081093594 @default.
• W2008471208 cites W2081577917 @default.
• W2008471208 cites W2083437069 @default.
• W2008471208 cites W2083726090 @default.
• W2008471208 cites W2084534301 @default.
• W2008471208 cites W2085480583 @default.
• W2008471208 cites W2090926682 @default.
• W2008471208 cites W2093007266 @default.
• W2008471208 cites W2093596089 @default.
• W2008471208 cites W2094406892 @default.
• W2008471208 cites W2095440126 @default.
• W2008471208 cites W2096678924 @default.
• W2008471208 cites W2097382995 @default.
• W2008471208 cites W2098412535 @default.
• W2008471208 cites W2098429685 @default.
• W2008471208 cites W2099238800 @default.
• W2008471208 cites W2106789666 @default.
• W2008471208 cites W2107636010 @default.
• W2008471208 cites W2108337314 @default.
• W2008471208 cites W2109005000 @default.
• W2008471208 cites W2112807945 @default.
• W2008471208 cites W2119308535 @default.
• W2008471208 cites W2120406858 @default.
• W2008471208 cites W2120476949 @default.
• W2008471208 cites W2121594719 @default.
• W2008471208 cites W2126448684 @default.
• W2008471208 cites W2126915497 @default.
• W2008471208 cites W2133756116 @default.
• W2008471208 cites W2133885485 @default.
• W2008471208 cites W2135624268 @default.
• W2008471208 cites W2136596547 @default.
• W2008471208 cites W2138687800 @default.
• W2008471208 cites W2146833311 @default.
• W2008471208 cites W2147535764 @default.
• W2008471208 cites W2147829987 @default.
• W2008471208 cites W2148845753 @default.

• next